Thesis icon

Thesis

Perinatal outcomes in HIV-positive women

Abstract:

In 2015, the majority (80%) of the 1.2 million HIV-positive pregnant women globally, most of whom reside in sub-Saharan Africa (91%), received antiretroviral treatment (ART) for the prevention-of- mother-to-child-transmission (PMTCT). The use of Highly Active Antiretroviral Treatment (HAART) during pregnancy improves maternal health, reduces mother-to-child-transmission to <1%, and reduces horizontal HIV-transmission to serodiscordant couples. Consequently, in 2016, WHO recommended ...

Expand abstract

Actions


Access Document


Authors


More by this author
Division:
MSD
Department:
Women's and Reproductive Health
Role:
Author

Contributors

Role:
Contributor
Role:
Supervisor
Role:
Supervisor
More from this funder
Name:
Skye Foundation
Funding agency for:
Wedi, O
More from this funder
Name:
Oppenheimer Scholarship
Funding agency for:
Wedi, O
More from this funder
Name:
Rhodes Trust
Funding agency for:
Wedi, O
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford
UUID:
uuid:6c773313-364a-4044-bb02-c0058392caa7
Deposit date:
2018-08-23

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP